Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer)

Technology appraisal guidance
Reference number: TA23
Published: 26 April 2001
Last updated: 03 March 2016

Appendix B: proposal paper presented to the Institute's Guidance Executive

Appendix B: proposal paper presented to the Institute's Guidance Executive

Appendix B: proposal paper presented to the Institute's Guidance Executive
25 March 2011
(230.93 Kb 7 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 24 March 2011